• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Stuart Butler, PhD, Identifies Ways to Approach Cost

Article

Dr. Butler answers why he is not confident that costs will ever be controlled.

Stuart Butler, PhD, Distinguished Fellow and Director, Center for Policy Innovation, The Heritage Foundation, states that the cost curve will never go down on the track we are currently on. Dr. Butler addresses the need for new approaches to bending the curve.

Related Videos
Interview with Miriam Freimer, MD, The Ohio State University Wexner Medical Center
Merrill H. Stewart, MD
Dr Carrie Kitko
Jeffrey Fitzgerald, JD
Dr Carrie Kitko
Related Content
Graphic of a person cutting a health care price tag in half | Image credit: retrostar - stock.adobe.com

The Future of Drug Pricing: Most Favored Nation, PBMs, and Patient Access

July 11th 2025
Article

During the Reshaping Rx: Navigating 2025 Drug Pricing Policies webinar, panelists discussed the Most Favored Nation executive order, bills aimed at pharmacy benefit managers (PBMs), and other drug pricing policies.

Read More

Managed Care Cast

Managed Care Cast News Roundup: July 8, 2025

July 8th 2025
Podcast

Medical societies challenge HHS Secretary Robert F. Kennedy Jr's COVID-19 vaccine rollbacks, and more news updates from the week.

Listen

Medicaid | Image credit: Andrii - stock.adobe.com

Experts Highlight Consequences of Medicaid Rollbacks Due to Budget Bill

July 10th 2025
Article

A webinar held by KFF on July 9 emphasized the immediate effects of the new budget bill, highlighting the impacts on Medicaid and health spending in the next decade.

Read More

Managed Care Cast

Why Collaborative Care Is the Path Forward for Mental Health Care: Anna Bobb, MPH

July 1st 2025
Podcast

Explore how the Collaborative Care Model enhances mental health access in this episode featuring Anna Bobb, MPH, executive director of the Path Forward coalition.

Listen

While accommodations can improve quality of life for patients with DMD and foster independence, the costs of home and ve modifications fall mostly on the families of patients. | Image credit: Nadzeya - stock.adobe.com

Accommodations as DMD Progresses Incur Substantial Household Costs

July 10th 2025
Article

Families caring for individuals with Duchenne muscular dystrophy (DMD) face significant financial burdens from necessary home and vehicle modifications to enhance quality of life.

Read More

A cornerstone of the proposed guidance is the emphasis on robust clinical trial design and appropriate patient selection. | Image Credit: wladimir1804 - stock.adobe.com

FDA Releases Draft Guidance for MDS Drug Development

July 10th 2025
Article

The FDA's new guidance shapes drug development for myelodysplastic syndromes (MDS), emphasizing trial design, patient selection, and safety reporting for better treatment outcomes.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.